Literature DB >> 2492575

Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.

N A Hosken1, M J Bevan, F R Carbone.   

Abstract

Previous studies have shown that glutaraldehyde-fixed cells can present fragmented, but not native, Ag to class II-restricted T cells. This presumably occurs via direct binding of peptides to class II molecules at the cell surface. More recently, it has been shown that viable target cells can present peptides and endogenous, but not exogenous, protein Ag in association with class I MHC molecules to CTL. We have derived CTL specific for a chicken OVA peptide (OVA258-276) recognized in association with H-2Kb. These CTL recognize target cells that endogenously synthesize OVA and cells "loaded" with native OVA but fail to recognize target cells in the presence of exogenous native OVA. Thus, OVA must be intracellularly located to be processed and presented for CTL recognition. It remains unclear, however, whether exogenous peptides require internalization and further processing by target cells or are able to associate directly with class I molecules at the cell surface for CTL recognition. We provide evidence that glutaraldehyde-fixed cells can present synthetic peptides to H-2Kb- and H-2Db-restricted CTL and that such presentation does not require internalization or processing. The peptides used range in size from 16 to 48 amino acids in length. In contrast, glutaraldehyde-fixed cells are incapable of presenting Ag to CTL specific for influenza nucleoprotein and OVA if the cells are fixed within 1 h of viral influenza infection or loading with OVA. Thus, CTL recognition of antigenic peptides appears to occur via direct binding of peptides to class I molecules at the cell surface and does not require any intracellular processing events.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492575

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.

Authors:  A M Mowat; A M Donachie; G Reid; O Jarrett
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

2.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

Authors:  A K Nussbaum; T P Dick; W Keilholz; M Schirle; S Stevanović; K Dietz; W Heinemeyer; M Groll; D H Wolf; R Huber; H G Rammensee; H Schild
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  The antigen self-presentation function of the cytotoxic T-cell clone 10BK.1 depends on reciprocal peptide presentation.

Authors:  M S Staege; T Dick; R Ertl; U Jahnel; H Nawrath; H G Rammensee; A B Reske-Kunz
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

4.  CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.

Authors:  Norma Olivares-Zavaleta; William M Whitmire; Laszlo Kari; Gail L Sturdevant; Harlan D Caldwell
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

5.  Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.

Authors:  M T Bejarano; M G Masucci; A Morgan; B Morein; G Klein; E Klein
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.

Authors:  P Moy; Y Daikh; B Pepinsky; D Thomas; S Fawell; J Barsoum
Journal:  Mol Biotechnol       Date:  1996-10       Impact factor: 2.695

7.  Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.

Authors:  Y Nakagawa; T Takeshita; J A Berzofsky; H Takahashi
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

8.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.

Authors:  J F Bukowski; I Kurane; C J Lai; M Bray; B Falgout; F A Ennis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.

Authors:  A R Hayward; R Burger; R Scheper; A M Arvin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.

Authors:  A B Kulkarni; H C Morse; J R Bennink; J W Yewdell; B R Murphy
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.